
PhaseV
Develops a platform for adaptive clinical trial design and closed-loop execution.
About
PhaseV provides AI/ML-driven solutions to optimize clinical development for biopharma sponsors and CROs. Their platform offers tools like Trial Optimizer, Response Optimizer, Portfolio Optimizer, and ClinOps Optimizer to improve trial design, decision-making, and operations, leading to faster, more efficient, and accurate clinical trials. PhaseV aims to increase trial success rates, enable sharper strategic decisions, and optimize the use of existing data.
Similar companies
AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.
Shares Life Sciences, Drug Discovery
AI-powered patient-centric drug simulations to accelerate and de-risk drug development.
Shares Life Sciences, Clinical Trials
Revolutionizing drug design using quantum computing, AI, and personalized medicine.
Shares Life Sciences, Drug Discovery
Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
Shares Life Sciences, Drug Discovery
Shares Life Sciences, Drug Discovery
AI-driven platform for protein-level disease mapping and drug discovery.
Shares Life Sciences, Drug Discovery
Key facts
- Website
- phasevtrials.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 2023
- Employees
- 61
- Total funding
- $65M (Series A)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 13 May 2025 | Series A | $50M | Accel Partners, Insight Partners |
| 24 Oct 2023 | Seed | $15M | Viola Ventures |
Tech stack
Detected on phasevtrials.com and in its job posts, last scanned 9 Nov 2026. Run your own scan
- Backend
- Python
- Support
- HubSpot
- CMS / Builders
- Webflow
- CDN
- Cloudflare
- Hosting
- AWS, Google Cloud
- Email provider
- Google Workspace
- Hiring platform
- Greenhouse
- DevOps
- Docker, Kubernetes
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is PhaseV trustworthy and reputable?
StartupHub's Data Trust & Reputation score for PhaseV is 87 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has PhaseV raised?
PhaseV has raised a total of $65M in funding. The most recent round on record is Series A.
How many employees does PhaseV have?
PhaseV has approximately 61 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for PhaseV:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules


